Connect with us

Hi, what are you looking for?

Latest News

Fentanyl seized at Arizona port of entry in 3 months surpasses 12 months of 2022

Just three months into the new fiscal year, U.S Customs and Border Protection (CBP) officers have already intercepted a record amount of deadly fentanyl at the port of entry in Nogales, Arizona.

Area Port Director Michael W. Humphries reported Tuesday that the Nogales point of entry ‘has already surpassed the total amount of fentanyl seized throughout all of FY22, which was already a record year.’

The first three months of fiscal year 2023 were October, November and December 2022. Humphries did not share exact statistics, but CBP publishes data on drug seizures on its website.

CBP data from the Tuscon field office area of operations, which includes all land ports of entry in Arizona, except those in Yuma County, shows that nearly 4,600 pounds of fentanyl were seized in fiscal year 2022, an increase from 2,300 pounds in fiscal year 2021 and 1,300 pounds in fiscal year 2020.

Data is not available for December, but in October, CBP seized 670 pounds of fentanyl and 2,000 pounds were seized in November.

This post appeared first on FOX NEWS

You May Also Like


Mimiq, Inc is announcing today the launch of their new product, Mimiq Track, at CES as part of their latest product line to operate...


Genesis Trading, the cryptocurrency brokerage and lender that halted customer withdrawals in the aftermath of FTX collapse, believes it can sort out its financial...

Editor's Pick

If you haven’t been following the “Twitter Files” saga, the gist of it is that the US federal government routinely pressured pre-Musk Twitter, and...

Editor's Pick

In Risky Business: Why Insurance Markets Fail and What to Do About It (Yale University Press, 2023), economists Liran Einav (Stanford), Amy Finkelstein (MIT),...

Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2023